Pediatric Features of Genetic Predisposition to Polycystic Ovary Syndrome

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Pediatric Features of Genetic Predisposition to Polycystic Ovary Syndrome. / Zhu, Jia; Eliasen, Anders U; Aris, Izzuddin M; Stinson, Sara E; Holm, Jens-Christian; Hansen, Torben; Hivert, Marie-France; Bønnelykke, Klaus; Salem, Rany M; Hirschhorn, Joel N; Chan, Yee-Ming.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 109, No. 2, 2024, p. 380-388.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Zhu, J, Eliasen, AU, Aris, IM, Stinson, SE, Holm, J-C, Hansen, T, Hivert, M-F, Bønnelykke, K, Salem, RM, Hirschhorn, JN & Chan, Y-M 2024, 'Pediatric Features of Genetic Predisposition to Polycystic Ovary Syndrome', Journal of Clinical Endocrinology and Metabolism, vol. 109, no. 2, pp. 380-388. https://doi.org/10.1210/clinem/dgad533

APA

Zhu, J., Eliasen, A. U., Aris, I. M., Stinson, S. E., Holm, J-C., Hansen, T., Hivert, M-F., Bønnelykke, K., Salem, R. M., Hirschhorn, J. N., & Chan, Y-M. (2024). Pediatric Features of Genetic Predisposition to Polycystic Ovary Syndrome. Journal of Clinical Endocrinology and Metabolism, 109(2), 380-388. https://doi.org/10.1210/clinem/dgad533

Vancouver

Zhu J, Eliasen AU, Aris IM, Stinson SE, Holm J-C, Hansen T et al. Pediatric Features of Genetic Predisposition to Polycystic Ovary Syndrome. Journal of Clinical Endocrinology and Metabolism. 2024;109(2):380-388. https://doi.org/10.1210/clinem/dgad533

Author

Zhu, Jia ; Eliasen, Anders U ; Aris, Izzuddin M ; Stinson, Sara E ; Holm, Jens-Christian ; Hansen, Torben ; Hivert, Marie-France ; Bønnelykke, Klaus ; Salem, Rany M ; Hirschhorn, Joel N ; Chan, Yee-Ming. / Pediatric Features of Genetic Predisposition to Polycystic Ovary Syndrome. In: Journal of Clinical Endocrinology and Metabolism. 2024 ; Vol. 109, No. 2. pp. 380-388.

Bibtex

@article{950ff4b54041433a98694478afdaa148,
title = "Pediatric Features of Genetic Predisposition to Polycystic Ovary Syndrome",
abstract = "Context: Polycystic ovary syndrome (PCOS) has historically been conceptualized as a disorder of the reproductive system in women. However, offspring of women with PCOS begin to show metabolic features of PCOS in childhood, suggestive of childhood manifestations. Objective: To identify childhood manifestations of genetic risk for PCOS. Methods: We calculated a PCOS polygenic risk score (PRS) for 12 350 girls and boys in 4 pediatric cohorts—ALSPAC (UK), COPSAC (Denmark), Project Viva (USA), and The HOLB{\AE}K Study (Denmark). We tested for association of the PRS with PCOS-related phenotypes throughout childhood and with age at pubarche and age at peak height velocity and meta-analyzed effects across cohorts using fixedeffect models. Results: Higher PRS for PCOS was associated with higher body mass index in midchildhood (0.05 kg/m2 increase per 1 SD of PRS, 95% CI 0.03, 0.07, P = 3 × 10−5 ) and higher risk of obesity in early childhood (OR 1.34, 95% CI 1.13, 1.59, P = .0009); both persisted through late adolescence (P all ≤.03). Higher PCOS PRS was associated with earlier age at pubarche (0.85-month decrease per 1 SD of PRS, 95% CI −1.44, −0.26, P = .005) and younger age at peak height velocity (0.64-month decrease per 1 SD of PRS, 95% CI −0.94, −0.33, P = 4 × 10−5 ). Conclusion: Genetic risk factors for PCOS are associated with alterations in metabolic, growth, and developmental traits in childhood. Thus, PCOS may not simply be a condition that affects women of reproductive age but, rather, a possible manifestation of an underlying condition that affects both sexes starting in early life.",
author = "Jia Zhu and Eliasen, {Anders U} and Aris, {Izzuddin M} and Stinson, {Sara E} and Jens-Christian Holm and Torben Hansen and Marie-France Hivert and Klaus B{\o}nnelykke and Salem, {Rany M} and Hirschhorn, {Joel N} and Yee-Ming Chan",
note = "{\textcopyright} The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.",
year = "2024",
doi = "10.1210/clinem/dgad533",
language = "English",
volume = "109",
pages = "380--388",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "2",

}

RIS

TY - JOUR

T1 - Pediatric Features of Genetic Predisposition to Polycystic Ovary Syndrome

AU - Zhu, Jia

AU - Eliasen, Anders U

AU - Aris, Izzuddin M

AU - Stinson, Sara E

AU - Holm, Jens-Christian

AU - Hansen, Torben

AU - Hivert, Marie-France

AU - Bønnelykke, Klaus

AU - Salem, Rany M

AU - Hirschhorn, Joel N

AU - Chan, Yee-Ming

N1 - © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.

PY - 2024

Y1 - 2024

N2 - Context: Polycystic ovary syndrome (PCOS) has historically been conceptualized as a disorder of the reproductive system in women. However, offspring of women with PCOS begin to show metabolic features of PCOS in childhood, suggestive of childhood manifestations. Objective: To identify childhood manifestations of genetic risk for PCOS. Methods: We calculated a PCOS polygenic risk score (PRS) for 12 350 girls and boys in 4 pediatric cohorts—ALSPAC (UK), COPSAC (Denmark), Project Viva (USA), and The HOLBÆK Study (Denmark). We tested for association of the PRS with PCOS-related phenotypes throughout childhood and with age at pubarche and age at peak height velocity and meta-analyzed effects across cohorts using fixedeffect models. Results: Higher PRS for PCOS was associated with higher body mass index in midchildhood (0.05 kg/m2 increase per 1 SD of PRS, 95% CI 0.03, 0.07, P = 3 × 10−5 ) and higher risk of obesity in early childhood (OR 1.34, 95% CI 1.13, 1.59, P = .0009); both persisted through late adolescence (P all ≤.03). Higher PCOS PRS was associated with earlier age at pubarche (0.85-month decrease per 1 SD of PRS, 95% CI −1.44, −0.26, P = .005) and younger age at peak height velocity (0.64-month decrease per 1 SD of PRS, 95% CI −0.94, −0.33, P = 4 × 10−5 ). Conclusion: Genetic risk factors for PCOS are associated with alterations in metabolic, growth, and developmental traits in childhood. Thus, PCOS may not simply be a condition that affects women of reproductive age but, rather, a possible manifestation of an underlying condition that affects both sexes starting in early life.

AB - Context: Polycystic ovary syndrome (PCOS) has historically been conceptualized as a disorder of the reproductive system in women. However, offspring of women with PCOS begin to show metabolic features of PCOS in childhood, suggestive of childhood manifestations. Objective: To identify childhood manifestations of genetic risk for PCOS. Methods: We calculated a PCOS polygenic risk score (PRS) for 12 350 girls and boys in 4 pediatric cohorts—ALSPAC (UK), COPSAC (Denmark), Project Viva (USA), and The HOLBÆK Study (Denmark). We tested for association of the PRS with PCOS-related phenotypes throughout childhood and with age at pubarche and age at peak height velocity and meta-analyzed effects across cohorts using fixedeffect models. Results: Higher PRS for PCOS was associated with higher body mass index in midchildhood (0.05 kg/m2 increase per 1 SD of PRS, 95% CI 0.03, 0.07, P = 3 × 10−5 ) and higher risk of obesity in early childhood (OR 1.34, 95% CI 1.13, 1.59, P = .0009); both persisted through late adolescence (P all ≤.03). Higher PCOS PRS was associated with earlier age at pubarche (0.85-month decrease per 1 SD of PRS, 95% CI −1.44, −0.26, P = .005) and younger age at peak height velocity (0.64-month decrease per 1 SD of PRS, 95% CI −0.94, −0.33, P = 4 × 10−5 ). Conclusion: Genetic risk factors for PCOS are associated with alterations in metabolic, growth, and developmental traits in childhood. Thus, PCOS may not simply be a condition that affects women of reproductive age but, rather, a possible manifestation of an underlying condition that affects both sexes starting in early life.

U2 - 10.1210/clinem/dgad533

DO - 10.1210/clinem/dgad533

M3 - Journal article

C2 - 37690116

VL - 109

SP - 380

EP - 388

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 2

ER -

ID: 368207892